: iStockAnalyst.com Symbols Feed

CombiMatrix: Array Of Sunshine In '09?

Thu, 15 Jan 2009 14:08:00 GMT

The accompanying table (click to enlarge) includes statistics for all 40 companies included in the ETF Innovators Emerging Diagnostics Index of stocks with market caps of less than $150M and an average market value of $50M. The index has lost nearly 54% of its value in the past year, compared to declines of about 40% each for the S&P 500 SPDR ETF (SPY) + iShares Russell Micro-Cap ETF (IWC), 29% for the Healthcare Sector SPDR (XLV), and 15% for the SPDR S&P Biotech ETF (XBI).[More...]

A New Emerging Diagnostics Index

Fri, 26 Dec 2008 15:27:00 GMT

The accompanying table (click to enlarge) includes 39 companies in the ETF Innovators (ETFI) Emerging Diagnostics Index of U.S.-listed stocks with market caps of $10-$200M. The index includes diabetes care device makers such as DexCom (DXCM), personalized medicine lab service providers such as Clarient (CLRT), clinical diagnostic test developers such as OraSure (OSUR), diagnostic imaging service providers such as Virtual Radiologic (VRAD), diagnostic equipment makers such as Vision Sciences (VSCI), and genetic[More...]

Just 18 Stocks To Watch Today!

Mon, 09 Jun 2008 15:40:02 GMT

AAPL oh my god 3G is coming..developers conference…blehhhh..STFU you friggin geeks, I covered this stock last week, nothing’s changed[More...]

Vision-Sciences, Inc. Announces $3.3 Million in Revenue for Fiscal Q1 2010; 23% Revenue Growth Over Fiscal Q1 2009

Fri, 14 Aug 2009 20:47:00 GMT

ORANGEBURG, N.Y., Aug. 14, 2009 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) (Vision-Sciences) today announced results for its fiscal year 2010 first quarter ended June 30, 2009 (Q1 10).
For Q1 10, revenues were $3.3 million, an increase of $622 thousand, or 23%, over our fiscal year 2009 first quarter ended June 30, 2008 (Q1 09).
Abbreviated results (in '000), except for per share data, for Q1 10 compared to Q1 09 are as follows:

[More...]

Vision-Sciences, Inc. Announces $3.3 Million in Revenue for Fiscal Q1 2010

Fri, 14 Aug 2009 20:25:00 GMT

Vision-Sciences, Inc., today announced results for its fiscal year 2010 first quarter ended June 30, 2009 . For Q1 10, revenues were $3.3 million, an increase of $622 thousand, or 23%, over our fiscal year 2009 first quarter ended June 30, 2008 . Loss from operations in Q1 10 was $2.5 million, compared to $3.2 million in Q1 09, a decrease of $761 thousand.[More...]

Vision-Sciences, Inc. Schedules Fiscal Q1 2010 Conference Call for August 17, 2009

Fri, 14 Aug 2009 13:57:00 GMT

Vision-Sciences, Inc., will issue results for its fiscal year 2010 first quarter ended June 30, 2009 today after the market closes. Vision-Sciences will host a conference call to discuss Q1 10 results and provide an update on the company on August 17, 2009 at 8:30 am EDT. The dial-in number for the call is 888.280.4443. Please dial in five minutes prior to the call to register. A recording of the call will be available through August 24, 2009. The replay dial-in is 888.203.1112. The replay pass code is 2425696. The call may also be accessed via a live audio webcast available in the investor relations section of Vision-Sciences website at www.visionsciences.com. The audio webcast of the call will be archived and available for replay through the website.[More...]

Vision-Sciences, Inc. Announces Election of New Director to Fill Vacancy On the Board

Wed, 15 Jul 2009 15:47:00 GMT

ORANGEBURG, N.Y., July 15, 2009 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) (Vision-Sciences) announced today that its Board of Directors elected Lothar Koob to serve as a member of its Board, effective immediately.
Mr. Koob will be an independent member on the Board.
Mr. Koob's appointment will fill the vacancy on the Board and the audit and compensation committees caused by Mr. Kenneth Anstey's resignation from the Board, which the Board received notice of on July 11, 2009.

[More...]

Vision-Sciences, Inc. Announces Election of Independent Director and Compliance With NASDAQ Listing Requirements

Mon, 29 Jun 2009 16:55:00 GMT

Vision-Sciences, Inc. announced today that its board of directors elected John J. Rydzewski to serve as a member of its Board, effective immediately. Mr. Rydzewski will be an independent member on the Board. He has also been appointed to serve on Vision-Sciences' audit committee and he will serve as the audit committee financial expert. Mr. Rydzewski's appointment will fill the vacancy on the board and the audit committee and will cure Vision-Sciences' non-compliance with NASDAQ listing requirements, each arising out of Mr. Wallace's resignation from the board effective May 15, 2009.[More...]

Vision-Sciences, Inc. Announces $12.8 Million in Revenue for Fiscal Year 2009; 34% Revenue Growth Over Fiscal Year 2008

Mon, 29 Jun 2009 15:46:00 GMT

ORANGEBURG, N.Y., June 29, 2009 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) (Vision-Sciences) today announced results for its fiscal year ended March 31, 2009 (FY 09).
Loss from operations in FY 09 was $12.7 million, compared to $10.7 million in FY 08, an increase of $2.1 million.
Abbreviated results (in '000), except for per share data, for FY 09 compared to FY 08 are as follows:

[More...]

Vision-Sciences, Inc. Announces $12.8 Million in Revenue for Fiscal Year 2009

Mon, 29 Jun 2009 14:56:00 GMT

Vision-Sciences, Inc., today announced results for its fiscal year ended March 31, 2009 . For FY 09, revenues were $12.8 million, an increase of $3.2 million, or 34%, over our fiscal year ended March 31, 2008 . Loss from operations in FY 09 was $12.7 million, compared to $10.7 million in FY 08, an increase of $2.1 million.[More...]

Vision-Sciences, Inc. Notifies NASDAQ of Director Resignation

Mon, 18 May 2009 20:34:00 GMT

Vision-Sciences, Inc., notified The Nasdaq Stock Market on May 15, 2009 that it does not meet the Nasdaq requirement that its audit committee contain three independent directors as a result of the resignation, effective May 15, 2009, of John J. Wallace as an independent board member and one of three members of its audit committee. Mr. Wallace resigned for personal reasons, not as a result of any disagreement with the management or the board of directors of Vision-Sciences. The board expressed its deep gratitude to Mr. Wallace for his many years of devoted service and guidance to Vision-Sciences.[More...]

Vision-Sciences, Inc. Announces Distribution Agreement With AMT Vantage Group Ltd.

Thu, 05 Mar 2009 13:24:00 GMT

Vision-Sciences, Inc., , announced today that it executed a distribution agreement with AMT Vantage Group Ltd. making AMT the exclusive marketing and distribution partner for the company's new line of advanced, video-based flexible endoscopes and EndoSheath technology for the urology and gastroenterology markets in Canada.[More...]

Vision-Sciences, Inc. Announces $3.6 Million in Revenue for Its Third Fiscal Quarter 2009

Fri, 13 Feb 2009 12:54:00 GMT

Vision-Sciences, Inc., today announced results for its third fiscal quarter ended December 31, 2008 and for the nine months ended December 31, 2008 . For Q3 09, revenues were $3.6 million, an increase of $1.8 million, or 96%, over our fiscal quarter ended December 31, 2007 . Sales for YTD 09 were $9.1 million, an increase of $1.7 million, or 23% compared to $7.4 million for the nine months ended December 31, 2007 . Loss from operations in Q3 09 was $3.1 million, compared to $2.1 million in Q3 08, an increase of $1.0 million. Loss from operations YTD 09 was $10.1 million, compared to $6.0 million YTD 08, an increase of $4.1 million.[More...]